About this scholarly article

C14. EMERGING THERAPIES IN INTERSTITIAL LUNG DISEASE - Pirfenidone, A Novel Anti-fibrotic Agent, Provides Higher Benefit For Idiopathic Pulmonary Fibrosis (IPF) Patients With Better Pulmonary Function by Ebina, Masahito; Kimura, Yuichiro; Ohta, Hiromitsu; Hisata, Shu; Tamada, Tsutomu; Nukiwa, Toshihiro is a scholarly article available to read on EtoBox.

Author

Ebina, Masahito; Kimura, Yuichiro; Ohta, Hiromitsu; Hisata, Shu; Tamada, Tsutomu; Nukiwa, Toshihiro

Publisher

American Thoracic Society

Published

2010